The European Hemodialysis Catheters Market Size was valued at USD 204.73 Million and is poised to reach USD 241.98 Million by the end of 2028, to grow at a steady CAGR of 3.40% from 2023 to 2028.
The rapid rise in chronic hemodialysis catheter treatments, further supported by the increasing number of kidney and end-stage renal disease patients, is driving Europe's hemodialysis market expansion (ESRD). Furthermore, the market is predicted to rise due to a lack of kidney donors for transplantation and technological advancements in dialysis equipment. In addition, the growing elderly population is an essential factor driving market expansion.
At the same time, patients with diabetes, hypertension, and high vascular access issues will fuel market growth in the upcoming years. Furthermore, market demand has been created by technology advancements and innovation of new user-friendly products such as reduced deterioration and implanted artificial kidneys.
Factors that contribute to market growth include increased use of hemodialysis catheters, increased patient awareness of hemodialysis treatment, increased popularity of antimicrobial-coated hemodialysis catheters, increased cases of blood infections (BSI), increased R&D expenditure for developing new hemodialysis products, and increased preference for home hemodialysis (HHD) treatment. Furthermore, due to the scarcity of kidney donors for transplantation, the demand for hemodialysis among CKD patients increases, boosting the market.
Limitations restrict the market's growth in medical reimbursement for dialysis procedures, as well as an increase in the risk of blood infection and thrombosis. High treatment costs and rigorous reimbursement regulations are restraining factors for the market, although the procedure's high risk is an issue. Low blood pressure (hypotension), muscle cramps, itching, sleeping problems, and anemia are side effects of hemodialysis catheters. It might lead to challenges and severe health issues in rare cases.
Hemodialysis increases the risk of death by two to three times, severe infection by five to ten times, and the likelihood of hospitalization by five to ten times, among other long-term risks. Therefore, infections and thrombosis are a significant concern for the hemodialysis catheter industry.
This research report on the Europe Hemodialysis Catheters Market has been segmented and sub-segmented into the following categories.
By Tip Configuration:
By End User:
Geographically, Europe has the world's highest proportion of older adults. According to predictions, the population of Europeans aged 65 and up will grow at a rate of almost 70%. As a result, the dialysis catheter market in Europe will expand as people in their later years are more likely to be affected by kidney-related illnesses.
The Germany Hemodialysis Catheters Market leads the European hemodialysis and peritoneal dialysis industry due to the pervasiveness of several pharmaceuticals and biotechnology firms, and the Rising government measures to improve healthcare infrastructure and technology advancement will support market growth.
The France Hemodialysis Catheters Market is expected to reach a decent CAGR because life expectancy has increased at a healthy rate, increasing the demand for dialysis catheters during the period. Albania is a southern European country. After a decade after being introduced to Albania, patients from Italy and Greece began traveling to Albania for hemodialysis therapy. Due to favorable health policies, the number of patients undergoing hemodialysis therapy has increased in Albania during the previous decade.
One of the expected points concerning the market growth of dialysis catheters in Georgia is the growing awareness of chronic diseases and the increasing awareness of dialysis goods. In addition, one of the reasons for the rise in dialysis catheter use in Georgia is the expanding population.
KEY MARKET PLAYERS
Prominent Companies operating the Europe Hemodialysis Catheters Market Profiled in the Report are B. Braun Melsungen AG, Nipro Medical Corporation, Asahi Kasei Medical Co Ltd, Baxter International Inc, Nikkiso Co. Ltd, Fresenius Medical Care AG & Co. KGaA, Toray Medical Co Ltd.,
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: firstname.lastname@example.org